GS 2A3
Alternative Names: GS-2A3Latest Information Update: 19 Sep 2019
At a glance
- Originator Genisphere
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Discontinued Ovarian cancer
Most Recent Events
- 19 Sep 2019 Discontinued for Ovarian cancer in USA (unspecified route) (Genisphere pipeline,